Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04579588 · ClinicalTrials.gov registry record
Understanding Immunity to the Flu Vaccine in COVID-19 Patients
A clinical trial of Corona Virus Infection and Immunity, sponsored by Stanford University.
- Recruiting
- Registry status
- 230
- Enrollment target
- 1
- Study location
NCT04579588 is a study of Corona Virus Infection and Immunity that is actively recruiting participants, run by Stanford University. The registered enrollment target is 230 participants, below the 868-participant average among 15 other Corona Virus Infection trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04579588, a study of Corona Virus Infection and Immunity, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- 230 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to measure immunity to the flu vaccine over time in patients who have had COVID-19 and may have other medical conditions including obesity, type 2 diabetes, chronic fatigue, or long-term COVID-19 symptoms. Adults and children (age 9 to 64) who had been diagnosed with COVID-19 as well as controls without COVID-19 will be invited to participate in this study.
Conditions Studied
Interventions
- BIOLOGICAL Flu shot
Study Locations (1)
California
- Stanford University - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 230 participants |
| Start Date | 2020-10-29 |
| Est. Completion | 2028-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04579588
The ClinicalTrials.gov registry entry for NCT04579588 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 230 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 868-participant average among 15 other Corona Virus Infection trials with a reported enrollment target (74% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Corona Virus Infection appearing as the primary indexed condition, and to 1 intervention - of which Flu shot is the first listed.
NCT04579588 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04579588 about?
NCT04579588 is a clinical study titled "Understanding Immunity to the Flu Vaccine in COVID-19 Patients". The purpose of this study is to measure immunity to the flu vaccine over time in patients who have had COVID-19 and may have other medical conditions including obesity, type 2 diabetes, chronic fatigue, or long-term COVID-19 symptoms. Adults and children (age 9 to 64) who had been diagnosed with COV...
What is the current status of trial NCT04579588?
This trial is currently recruiting. The enrollment target is 230 participants. The study started on 2020-10-29. Estimated completion is 2028-04.
What conditions does trial NCT04579588 study?
This clinical trial studies the following conditions: Corona Virus Infection, Immunity, Flu Vaccine.
What interventions are being tested in trial NCT04579588?
The interventions under investigation include: Flu shot (BIOLOGICAL).
Who is sponsoring clinical trial NCT04579588?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04579588 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Corona Virus Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Risk Factors, Clinical Characteristics and Outcomes of Acute Infection With Coronavirus 2019 (COVID-19) In Children
RECRUITING
-
Determinants of SARS (Severe Acute Respiratory Syndrome)-COV2 (COVID-19) Persistence After Convalescence
RECRUITING
-
A Study to Explore the Role of Gut Flora in COVID-19 Infection
RECRUITING
-
KIDney Injury in Times of COVID-19 (KIDCOV)
RECRUITING
-
SARS-CoV-2/COVID-19 Study of Next Generation Non-Invasive Passive Detection Technologies
ACTIVE NOT RECRUITING
-
Long Term Outcomes of Patients With COVID-19
ACTIVE NOT RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.